✦ LIBER ✦

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats

✍ Scribed by Yoshikazu Fujimori; Kenji Katsuno; Kazuma Ojima; Ikumi Nakashima; Shigeru Nakano; Yukiko Ishikawa-Takemura; Hiroshi Kusama; Masayuki Isaji

Book ID: 113588148
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 608 KB
Volume: 609
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2009.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Empagliflozin, a novel potent and select

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

✍ G. Luippold; T. Klein; M. Mark; R. Grempler 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

Long-term treatment with empagliflozin,

Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats

✍ L. Thomas; R. Grempler; M. Eckhardt; F. Himmelsbach; A. Sauer; T. Klein; P. Eick 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

MP47-11 EFFECTS OF CHRONIC ADMINISTRATIO

MP47-11 EFFECTS OF CHRONIC ADMINISTRATION OF PDE5 INHIBITOR COMBINED WITH GLYCEMIC CONTROL ON ERECTILE FUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS

✍ Choi, Woo Suk; Kwon, Oh Seong; Paick, Jae-Seung; Kim, Soo Woong 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 174 KB

Celecoxib, a selective cyclooxygenase-2

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

✍ Surya P. Ayalasomayajula; Uday B. Kompella 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 232 KB